Regen BioPharma Inc (RGBP)

[Schuller]

Nothing legitimizes your program and science like world renowned Peers hopping aboard. Will make licensing so much easier which is only a matter of time. Licensing creates income which pays for more testing and thus more deals and starts a positive loop.

Koos has cleaned up a lot of debt, however I am hoping it's eliminated before any future announcements. We're getting close.